Craft BS - Search Results

1

Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer.

Tang SC, Capra CL, Ajebo GH, Meza-Junco J, Mairs S, Craft BS, Zhu X, Maihle N, Hillegass WB. Tang SC, et al. Among authors: craft bs. Int J Cancer. 2021 Apr 12;149(4):909-16. doi: 10.1002/ijc.33597. Online ahead of print. Int J Cancer. 2021. PMID: 33844843 Free PMC article.

2

Adjuvant biologic therapy for breast cancer.

Craft BS, Hortobagyi GN, Moulder SL. Craft BS, et al. Cancer J. 2007 May-Jun;13(3):156-61. doi: 10.1097/PPO.0b013e318074d80a. Cancer J. 2007. PMID: 17620764 Review.

3

Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.

Santos MF, Mannam VK, Craft BS, Puneky LV, Sheehan NT, Lewis RE, Cruse JM. Santos MF, et al. Among authors: craft bs. Exp Mol Pathol. 2014 Jun;96(3):367-74. doi: 10.1016/j.yexmp.2014.04.001. Epub 2014 Apr 13. Exp Mol Pathol. 2014. PMID: 24731923

4

The Will Rogers phenomenon, breast cancer and race.

Nittala MR, Mundra EK, Packianathan S, Mehta D, Smith ML, Woods WC, McKinney S, Craft BS, Vijayakumar S. Nittala MR, et al. Among authors: craft bs. BMC Cancer. 2021 May 17;21(1):554. doi: 10.1186/s12885-021-08125-8. BMC Cancer. 2021. PMID: 34001038 Free PMC article.

5

The changing face of phase 1 cancer clinical trials: new challenges in study requirements.

Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, Karp DD. Craft BS, et al. Cancer. 2009 Apr 15;115(8):1592-7. doi: 10.1002/cncr.24171. Cancer. 2009. PMID: 19165808 Free PMC article.

6

Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment.

Green TL, Cruse JM, Lewis RE, Craft BS. Green TL, et al. Among authors: craft bs. Exp Mol Pathol. 2013 Oct;95(2):174-9. doi: 10.1016/j.yexmp.2013.06.013. Epub 2013 Jul 4. Exp Mol Pathol. 2013. PMID: 23831428

7

Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells.

Green TL, Santos MF, Ejaeidi AA, Craft BS, Lewis RE, Cruse JM. Green TL, et al. Among authors: craft bs. Exp Mol Pathol. 2014 Aug;97(1):44-8. doi: 10.1016/j.yexmp.2014.05.003. Epub 2014 May 14. Exp Mol Pathol. 2014. PMID: 24836676

8

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

Blanchard Z, Paul BT, Craft B, ElShamy WM. Blanchard Z, et al. Breast Cancer Res. 2015 Jan 13;17(1):5. doi: 10.1186/s13058-014-0512-9. Breast Cancer Res. 2015. PMID: 25583261 Free PMC article.

9

Real World and Public Health Perspectives of Intraoperative Radiotherapy in Early-Stage Breast Cancer: A Multidisciplinary Analysis Beyond the Statistical Facts.

Vijayakumar S, Nittala MR, Buddala V, Mobit P, Duggar WN, Yang CC, Lirette ST, Mundra E, Ahmed HZ, Berry SM, Craft BS, Woods WC, Otts J, Rahimi A, Dobbs T. Vijayakumar S, et al. Among authors: craft bs. Cureus. 2023 Mar 20;15(3):e36432. doi: 10.7759/cureus.36432. eCollection 2023 Mar. Cureus. 2023. PMID: 37025715 Free PMC article. Review.

10

Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.

Ejaeidi AA, Craft BS, Puneky LV, Lewis RE, Cruse JM. Ejaeidi AA, et al. Among authors: craft bs. Exp Mol Pathol. 2015 Aug;99(1):163-72. doi: 10.1016/j.yexmp.2015.06.002. Epub 2015 Jun 14. Exp Mol Pathol. 2015. PMID: 26079660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page